Russell Jones

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial

Anthony Barnett, Ambrish Mithal, Jenny Manassie et al. · The Lancet Diabetes & Endocrinology · 2014 · 567 citations

Diabetes Management, Insulin Management, Diabetes +8

Global Climate Change and Sea Level Rise: Potential Losses of Intertidal Habitat for Shorebirds

Hector Galbraith, Russell Jones, R. Park et al. · Waterbirds · 2002 · 380 citations

Engineering, Marine Systems, Oceanography +21

Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial

Christopher S. Kovács, V Seshiah, Ros Swallow et al. · Diabetes Obesity and Metabolism · 2013 · 379 citations

Climate change risks to US infrastructure: impacts on roads, bridges, coastal development, and urban drainage

James E. Neumann, Jason C. Price, Paul Chinowsky et al. · Climatic Change · 2014 · 193 citations · Full text

Urban Vulnerability, Engineering, Urban Climate Impact +24

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial

Anthony Barnett, Holger Huisman, Russell Jones et al. · The Lancet · 2013 · 178 citations

Metabolic Syndrome, Common Antidiabetes Treatments, Diabetes Management +9